$PRTA

Prothena Corp Public Ltd Co

Nasdaq · Healthcare · Pharmaceutical Preparations · Dublin 2, Ireland

PRTA chart

What traders are saying about $PRTA

Latest posts

Prothena Corp Public Ltd Co news

Prothena Corp Public Ltd Co key financials

USD2025202420232022
Revenue$9.7M$135.2M$91.4M$53.9M
Net income-$244.1M-$122.3M-$147.0M-$116.9M
Diluted EPS$-4.53$-2.27$-2.76$-2.47
Total assets (year end)$326.8M$547.1M$696.4M$758.0M
Cash and equivalents (year end)$307.5M$471.4M$618.8M$710.4M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Prothena Corp Public Ltd Co

Ticker
PRTA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Dublin 2, Ireland
Incorporated in
Ireland
Fiscal year end
December 31
SEC CIK
1559053
Former names
Prothena Corp plc, Neotope Corp Ltd

Frequently asked questions

What exchange is Prothena Corp Public Ltd Co listed on?

Prothena Corp Public Ltd Co trades on the Nasdaq under the ticker symbol PRTA.

What industry is Prothena Corp Public Ltd Co in?

Prothena Corp Public Ltd Co is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Prothena Corp Public Ltd Co headquartered?

Prothena Corp Public Ltd Co's business address on file with the SEC is in Dublin 2, Ireland.

When does Prothena Corp Public Ltd Co's fiscal year end?

Prothena Corp Public Ltd Co's fiscal year ends on December 31.

How much revenue did Prothena Corp Public Ltd Co report?

Prothena Corp Public Ltd Co reported $9.7M in revenue for calendar year 2025, according to its SEC filings.